See All Slides - tctmd.com

Slides

Presentation TCT 2019

Slovenia Presents: VIV Treatment of Degenerated Bio-Bentall With TAVI

Presenter: Matjaz Bunc

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Bill Gogas

September 26, 2019

Presentation TCT 2019

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Presenter: Greg Kaluza

September 26, 2019

Presentation TCT 2019

Patient Selection for MitraClip in Heart Failure With FMR: What Are the “COAPT Criteria” and Where (if Anywhere) Might They Be Stretched?

Presenter: Milton Packer

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Ning Guo

September 26, 2019

Presentation TCT 2019

Case Introduction

Presenter: Lily Li

September 26, 2019

Presentation TCT 2019

Defining the TR Population: Key Role of Imaging

Presenter: Rebecca Hahn

September 26, 2019

Presentation TCT 2019

FMR: Two-Year MITRA-FR Data and Reconciliation With COAPT

Presenter: Guillaume Leurent

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

Presentation TCT 2019

Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

Presenter: Muralidhar Padala

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Advertisement

Slides

Slovenia Presents: VIV Treatment of Degenerated Bio-Bentall With TAVI

How Would I Treat?

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Patient Selection for MitraClip in Heart Failure With FMR: What Are the “COAPT Criteria” and Where (if Anywhere) Might They Be Stretched?

How Would I Treat?

Case Introduction

Defining the TR Population: Key Role of Imaging

FMR: Two-Year MITRA-FR Data and Reconciliation With COAPT

Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content